BrainStorm looks at the future through a societal lens as the US population transitions to minority majority. 

The Centers for Medicare and Medicaid Services (CMS), the federal health insurance program for people 65 plus, announced its decision to deny covering Biogen’s Aduhelm and all future anti-amyloid treatments under what is known as a Coverage with Evidence Development (CED).

The excitement of a new year brings with it an opportunity to reset our priorities. And what could be more important than taking care of

Families are complicated. Dale Atkins, PhD, author of “The Kindness Advantage”, talks with Meryl Comer about how to manage stress with family, particularly in the

This SPECIAL EDITION of BrainStorm gives voice to those living with dementia. Hear from three individuals: journalist, Greg O'Brien, The Very Reverend Tracey Lind, and